Page last updated: 2024-09-04

gadolinium dtpa and trelstar

gadolinium dtpa has been researched along with trelstar in 1 studies

Compound Research Comparison

Studies (gadolinium dtpa)	Trials (gadolinium dtpa)	Recent Studies (post-2010) (gadolinium dtpa)	Studies (trelstar)	Trials (trelstar)	Recent Studies (post-2010) (trelstar)
12,654	664	4,051	1,998	483	490

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chanson, P; Schaison, G	1

Other Studies

1 other study(ies) available for gadolinium dtpa and trelstar

Article	Year
Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:7 Topics: Adenoma; Aged; Contrast Media; Cyproterone Acetate; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Pituitary Apoplexy; Pituitary Neoplasms; Prostatic Neoplasms; Triptorelin Pamoate	1995

Article

Year

Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma.

The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:7

Topics: Adenoma; Aged; Contrast Media; Cyproterone Acetate; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Pituitary Apoplexy; Pituitary Neoplasms; Prostatic Neoplasms; Triptorelin Pamoate

1995